Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,834 | 375 | 99.3% |
| Education | $40.25 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $794.97 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $752.64 | 47 | $0 (2024) |
| Novo Nordisk Inc | $675.80 | 51 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $623.11 | 47 | $0 (2023) |
| Merck Sharp & Dohme LLC | $349.72 | 28 | $0 (2024) |
| PFIZER INC. | $283.49 | 25 | $0 (2020) |
| GlaxoSmithKline, LLC. | $185.01 | 10 | $0 (2024) |
| ABBVIE INC. | $179.16 | 10 | $0 (2023) |
| Amarin Pharma Inc. | $162.79 | 11 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $155.28 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $694.96 | 36 | AstraZeneca Pharmaceuticals LP ($268.28) |
| 2023 | $891.68 | 50 | AstraZeneca Pharmaceuticals LP ($146.69) |
| 2022 | $969.41 | 54 | Lilly USA, LLC ($182.95) |
| 2021 | $907.88 | 61 | Lilly USA, LLC ($226.15) |
| 2020 | $801.85 | 56 | Janssen Pharmaceuticals, Inc ($156.56) |
| 2019 | $437.98 | 25 | Globus Medical, Inc. ($114.67) |
| 2018 | $562.81 | 45 | PFIZER INC. ($117.90) |
| 2017 | $607.47 | 51 | PFIZER INC. ($118.45) |
All Payment Transactions
378 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Insomnia | ||||||
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Biological | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Endocrinology | ||||||
| 03/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardio-renal | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 487 | 563 | $88,750 | $41,554 |
| 2022 | 11 | 518 | 597 | $90,105 | $42,858 |
| 2021 | 14 | 667 | 781 | $114,238 | $59,677 |
| 2020 | 17 | 964 | 1,117 | $138,315 | $68,001 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 142 | 142 | $28,400 | $17,269 | 60.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 126 | $20,790 | $6,970 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 98 | $22,540 | $6,674 | 29.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 56 | $5,040 | $4,028 | 79.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 23 | $4,980 | $3,536 | 71.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 61 | 61 | $2,440 | $1,779 | 72.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 19 | $3,040 | $744.35 | 24.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 12 | $900.00 | $415.44 | 46.2% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 12 | $480.00 | $105.42 | 22.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 14 | $140.00 | $30.80 | 22.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 151 | 151 | $30,200 | $18,830 | 62.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 158 | $24,275 | $7,388 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 81 | $17,510 | $5,798 | 33.1% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 18 | 24 | $5,040 | $3,789 | 75.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 47 | $4,095 | $3,197 | 78.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 47 | $1,880 | $1,320 | 70.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 16 | 20 | $3,200 | $809.95 | 25.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 18 | 18 | $1,350 | $630.98 | 46.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $675.00 | $538.15 | 79.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 12 | 13 | $1,690 | $514.54 | 30.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 19 | $190.00 | $42.13 | 22.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 158 | 158 | $31,620 | $20,549 | 65.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 113 | 161 | $32,150 | $12,814 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 137 | 199 | $28,030 | $11,306 | 40.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 58 | 58 | $3,770 | $3,770 | 100.0% |
About Dr. Robert Hart, M.D
Dr. Robert Hart, M.D is a Family Medicine healthcare provider based in Hickory, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326044504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hart, M.D has received a total of $5,874 in payments from pharmaceutical and medical device companies, with $694.96 received in 2024. These payments were reported across 378 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,834).
As a Medicare-enrolled provider, Hart has provided services to 2,636 Medicare beneficiaries, totaling 3,058 services with total Medicare billing of $212,089. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Hickory, NC
- Active Since 06/22/2005
- Last Updated 10/19/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326044504
Products in Payments
- XARELTO (Drug) $473.27
- FARXIGA (Drug) $431.15
- Ozempic (Drug) $348.67
- TRULICITY (Drug) $314.58
- BREZTRI (Drug) $292.69
- JARDIANCE (Drug) $244.83
- EMGALITY (Drug) $180.58
- Vascepa (Drug) $162.79
- JANUVIA (Drug) $155.43
- Kerendia (Drug) $155.28
- INVOKANA (Drug) $149.84
- QUVIVIQ (Drug) $131.41
- GEMTESA (Drug) $117.61
- Rybelsus (Drug) $116.02
- Quartex (Device) $114.67
- VRAYLAR (Drug) $105.90
- BELSOMRA (Drug) $102.25
- TRINTELLIX (Drug) $92.11
- SHINGRIX (Biological) $89.77
- ENTRESTO (Drug) $85.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hickory
Jonathan Wilson, Do, DO
Family Medicine — Payments: $31,125
Dr. Michael Desantis, M.d, M.D
Family Medicine — Payments: $12,291
David Duralia, M.d, M.D
Family Medicine — Payments: $11,991
Dr. Mary Britton, M.d, M.D
Family Medicine — Payments: $8,725
Robert Lee, Md, MD
Family Medicine — Payments: $8,629
Dr. Gregory Brooks, Md, MD
Family Medicine — Payments: $8,580